Hospira has introduced the latest version of TheraDoc Clinical Surveillance System to improve patient safety and prevent adverse events such as healthcare-associated infections (HAIs).

The TheraDoc platform enhancements are designed to help hospitals meet and improve upon evolving quality metrics and national patient safety goals.

Hospira said the new platform also helps clinicians easily identify antimicrobial resistant pathogens and drug-bug mismatches.

Improvements to the TheraDoc infection control assistant facilitate electronic reporting of HAIs to the National Healthcare Safety Network (NHSN) and provide a new infection control dashboard for reporting, data comparison and benchmarking.

Clinicians and healthcare institutions can use TheraDoc to automatically track and generate electronic reports regarding urinary tract infections (UTI), central line insertion practices (CLIP), laboratory-identified multi-drug resistant organisms (MDRO) and C. difficile-associated disease (CDAD) events.

The additional functionality will help to decrease manual sorting of laboratory results and streamline public health reporting.